Vor Biopharma Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.21
|
|
Average Rating
|
4.38
|
|
# Strong Buys
|
4
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.61
|
-0.63
|
-0.02
|
-3.28%
|
|
2022-06-30
|
-0.66
|
-0.58
|
0.08
|
12.12%
|
|
2022-03-31
|
-0.51
|
-0.61
|
-0.10
|
-19.61%
|
|
2021-12-31
|
-0.57
|
-0.48
|
0.09
|
15.79%
|
|
2021-09-30
|
-0.62
|
-0.50
|
0.12
|
19.35%
|
|
2021-06-30
|
-0.50
|
-0.50
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.62
|
-0.67
|
-0.05
|
-8.06%
|
|
2020-12-31
|
-4.40
|
-217.49
|
-213.09
|
-4842.95%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.82
|
|
2021-12-31
|
-2.15
|
|
2020-12-31
|
-233.56
|
|
2019-12-31
|
-8.08
|
|
2018-12-31
|
-1.33
|